Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies
Authors:
- F KilicaslanFKF Kilicaslan
- D O MartinDMD O Martin
- S MinorSMS Minor
- R StarlingRSR Starling
- N F MarroucheNMN F Marrouche
- S AlmahammedSAS Almahammed
- O M WazniOWO M Wazni
- S DuggalSDS Duggal
- R ZuzekRZR Zuzek
- H YamajiHYH Yamaji
- J CummingsJCJ Cummings
Abstract
Objective: To assess prospectively whether preimplantation B-type natriuretic peptide (BNP) and C reactive protein (CRP) concentrations predict future appropriate therapies from an implantable cardioverter-defibrillator (ICD). Design and setting: Prospective cohort study conducted in a tertiary cardiac care centre. Methods: 345 consecutive patients undergoing first time ICD implantation were prospectively studied. Serum BNP and CRP concentrations were obtained the day before ICD implantation. Patients were followed up with device interrogation to assess for appropriate shocks or antitachycardia pacing. Inappropriate therapies were excluded. Mean (SD) follow up was 13 (5) months. Results: Patients had ischaemic (71%), primary dilated (17%), and valvar or other cardiomyopathies (12%). About half (52%) had ICDs implanted for primary prevention. Sixty three (18%) received appropriate ICD therapies. Serum creatinine, β blocker, statin, and angiotensin converting enzyme inhibitor usage did not differ between therapy and no therapy groups. By univariate comparison, ejection fraction (p = 0.048), not taking amiodarone (p = 0.033), and BNP concentration (p = 0.0003) were risk factors for ICD therapy. However, by Cox regression multivariate analysis, only BNP above the 50th centile was a significant predictor (hazard ratio 2.19, 95% confidence interval 1.07 to 4.71, p = 0.040). Median BNP was 573 ng/l versus 243 ng/l in therapy and no therapy patients, respectively (p = 0.0003). More patients with BNP above the 50th centile (27% v 10%, p = 0.006) received ICD therapies. Conclusions: A single preimplantation BNP concentration determination is independently predictive of ICD therapies in patients with cardiomyopathies undergoing first time ICD implantation. CRP was not independently predictive of ICD therapies when compared with BNP.Keywords
This publication has 27 references indexed in Scilit:
- Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failureAmerican Heart Journal, 2004
- Heart Failure and the Risk of Shocks in Patients With Implantable Cardioverter DefibrillatorsCirculation, 2004
- Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and DeathNew England Journal of Medicine, 2004
- Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failureAmerican Heart Journal, 2003
- Apparent protective effect of increased left ventricular wall thickness in an ICD populationJournal of Cardiac Failure, 2003
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapyJACC, 2001
- Predictors of Outcome in Patients with Implantable Cardioverter DefibrillatorsCardiology, 1998
- Brain natriuretic peptide predicts mortality in the elderly.Heart, 1997
- Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE trial)The American Journal of Cardiology, 1994